• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM SARS-COV-2 TOTAL (COV2T); SARS-COV-2 TOTAL IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM SARS-COV-2 TOTAL (COV2T); SARS-COV-2 TOTAL IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/18/2022
Event Type  malfunction  
Manufacturer Narrative
An outside of the united states (ous) customer contacted the siemens customer care center (ccc) to report discordant, reactive (positive) results were obtained from two samples and the results were considered discordant compared to testing with an alternate method.One of these samples was also discordant to testing with a different lot of atellica im sars-cov-2 total.Qc was in range at the time of testing.The interpretation of results section of the instructions for use (ifu) states: "the system reports advia centaur cov2t assay results in index values or u/ml and as non-reactive or reactive: non-reactive: < 1.00 index (u/ml).These samples are considered negative for sars-cov-2 antibodies.Reactive:
 
Event Description
The customer reported atellica im sars-cov-2 total (cov2t) reactive (positive) results were obtained from two samples and the results were considered discordant compared to testing with an alternate method.One of these samples was also discordant to testing with a different lot of atellica im sars-cov-2 total.The reactive results were reported to the physician(s) who questioned the results.There are no reports that treatment was altered or prescribed or adverse health consequences due to the discordant, reactive atellica im sars-cov-2 total (cov2t) results.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2022-00088 on march 18, 2022.March 24, 2022, additional information: an outside of the united states (ous) customer contacted the siemens customer care center (ccc) to report discordant, reactive (positive) results were obtained from two samples and the results were considered discordant compared to testing with an alternate method.One of these samples was also discordant to testing with a different lot of atellica im sars-cov-2 total.Siemens healthcare diagnostics has completed the investigation into alleged differences in cov2t results compared to an alternate method and the difference of one sample between lot 012 and 013.Quality control and calibrations were appropriate for both kit lots at the time of testing.In review of in-house data, there is no data that showed patients positive on lot 12 but negative on lot 13.No patient history was available, and no further testing could be conducted as the kit lot 012 had expired.This appears to be a sample-specific issue however without further medical history siemens healthcare is unable to determine the root cause.No product nonconformance was identified.In section h6, the investigation finding, and investigation conclusion codes were updated.Mdr 1219913-2022-00088 supplemental 1 and mdr 1219913-2022-00089 supplemental 1 were filed for the same event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM SARS-COV-2 TOTAL (COV2T)
Type of Device
SARS-COV-2 TOTAL IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
barry memishian
333 coney street
east walpole, MA 02032
5082985306
MDR Report Key13831098
MDR Text Key297573137
Report Number1219913-2022-00088
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
EUA201367
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/19/2022
Device Model NumberN/A
Device Catalogue Number11206711
Device Lot Number012
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/19/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-